Rapid blood test startup Atomo Diagnostics is playing its part in the fight against coronavirus, signing a deal with French diagnostics company, NG Biotech, to supply up 2.465 million of its rapid, blood-based COVID-19 tests in 2020. The sale landed as the Sydney-based healthtech venture’s $30 million Initial Public Offer was oversubscribed at 20 cents per… Read more »
Europe-founded, New Zealand-trialled app Ada offers a virtual assessment of health symptoms in real time
To decrease the cost of hospital expenditure and relieve the time spent between patient and doctor is new healthtech app, Ada. The app is a diagnosis smartphone service that was built in Berlin and London with the input of more than 100 medical doctors and years of clinical research.